ACOR Historical PE Ratio image   This ACOR PE ratio history page last updated 5/23/2022
ACOR Historical PE Ratio Chart
PeriodPriceAdj. EPSAnnualizedPE
Q1 2022
5/11/2022
0.74-1.66-6.64NA
Q4 2021
3/9/2022
2.25-0.67-2.68NA
Q3 2021
11/9/2021
3.76-1.43-5.72NA
Q2 2021
8/5/2021
4.10-1.87-7.48NA
Q1 2021
5/6/2021
4.71-2.46-9.84NA
Q4 2020
3/4/2021
6.78-2.50-10.00NA
Q3 2020
11/3/2020
6.48-1.38-5.52NA
Q2 2020
8/4/2020
3.84-2.10-8.40NA
Q1 2020
5/5/2020
5.64-3.06-12.24NA
Q4 2019
2/13/2020
11.52-0.90-3.60NA
Q3 2019
11/4/2019
12.00-2.76-11.04NA
Q2 2019
8/1/2019
36.42-3.30-13.20NA
Q1 2019
5/2/2019
63.48-3.36-13.44NA
Q4 2018
2/14/2019
93.362.7010.808.6
Q3 2018
10/31/2018
114.661.024.0828.1
Q2 2018
8/2/2018
156.008.4033.604.6
Q1 2018
5/2/2018
139.200.843.3641.4
Q4 2017
2/15/2018
150.603.6614.6410.3
Q3 2017
10/31/2017
159.482.5810.3215.5
Q2 2017
7/27/2017
130.201.746.9618.7
Q1 2017
4/27/2017
93.30-0.48-1.92NA
Q4 2016
2/14/2017
143.100.301.20119.2
Q3 2016
10/27/2016
109.50-0.24-0.96NA
Q2 2016
7/28/2016
149.700.421.6889.1
Q1 2016
4/28/2016
164.040.421.6897.6
Q4 2015
2/11/2016
200.881.686.7229.9
Q3 2015
10/22/2015
209.521.867.4428.2
Q2 2015
7/30/2015
205.381.867.4427.6
Q1 2015
4/30/2015
180.420.903.6050.1
Q4 2014
2/12/2015
219.902.7611.0419.9
Q3 2014
10/30/2014
216.901.686.7232.3
Q2 2014
7/31/2014
175.622.5210.0817.4
Q1 2014
5/6/2014
191.220.120.48398.4
Q4 2013
2/13/2014
204.360.903.6056.8
Q3 2013
10/31/2013
183.662.289.1220.1
Q2 2013
8/1/2013
223.561.506.0037.3
Q1 2013
5/2/2013
218.160.542.16101.0
Q4 2012
2/13/2013
179.761.445.7631.2
Q3 2012
10/31/2012
143.702.289.1215.8
Q2 2012
7/31/2012
144.421.626.4822.3
Q1 2012
5/3/2012
143.941.144.5631.6
ACOR PE History Chart
PeriodPriceAdj. EPSTTMPE
Q1 2022
5/11/2022
0.74-1.66-5.63NA
Q4 2021
3/9/2022
2.25-0.67-6.43NA
Q3 2021
11/9/2021
3.76-1.43-8.26NA
Q2 2021
8/5/2021
4.10-1.87-8.21NA
Q1 2021
5/6/2021
4.71-2.46-8.44NA
Q4 2020
3/4/2021
6.78-2.50-9.04NA
Q3 2020
11/3/2020
6.48-1.38-7.44NA
Q2 2020
8/4/2020
3.84-2.10-8.82NA
Q1 2020
5/5/2020
5.64-3.06-10.02NA
Q4 2019
2/13/2020
11.52-0.90-10.32NA
Q3 2019
11/4/2019
12.00-2.76-6.72NA
Q2 2019
8/1/2019
36.42-3.30-2.94NA
Q1 2019
5/2/2019
63.48-3.368.767.2
Q4 2018
2/14/2019
93.362.7012.967.2
Q3 2018
10/31/2018
114.661.0213.928.2
Q2 2018
8/2/2018
156.008.4015.4810.1
Q1 2018
5/2/2018
139.200.848.8215.8
Q4 2017
2/15/2018
150.603.667.5020.1
Q3 2017
10/31/2017
159.482.584.1438.5
Q2 2017
7/27/2017
130.201.741.3298.6
Q1 2017
4/27/2017
93.30-0.480.00NA
Q4 2016
2/14/2017
143.100.300.90159.0
Q3 2016
10/27/2016
109.50-0.242.2848.0
Q2 2016
7/28/2016
149.700.424.3834.2
Q1 2016
4/28/2016
164.040.425.8228.2
Q4 2015
2/11/2016
200.881.686.3031.9
Q3 2015
10/22/2015
209.521.867.3828.4
Q2 2015
7/30/2015
205.381.867.2028.5
Q1 2015
4/30/2015
180.420.907.8623.0
Q4 2014
2/12/2015
219.902.767.0831.1
Q3 2014
10/30/2014
216.901.685.2241.6
Q2 2014
7/31/2014
175.622.525.8230.2
Q1 2014
5/6/2014
191.220.124.8039.8
Q4 2013
2/13/2014
204.360.905.2239.1
Q3 2013
10/31/2013
183.662.285.7631.9
Q2 2013
8/1/2013
223.561.505.7638.8
Q1 2013
5/2/2013
218.160.545.8837.1
Q4 2012
2/13/2013
179.761.446.4827.7
Q3 2012
10/31/2012
143.702.28NANA
Q2 2012
7/31/2012
144.421.62NANA
Q1 2012
5/3/2012
143.941.14NANA
Quotes delayed 20 minutes

Email EnvelopeFree ACOR Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Acorda Therapeutics (ACOR) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

ACRS PE Ratio History
ACRX PE Ratio History
ADGI PE Ratio History
ADIL PE Ratio History
ADMA PE Ratio History
ADMP PE Ratio History
ADMS PE Ratio History
ADPT PE Ratio History
ADTX PE Ratio History
ADUS PE Ratio History
How should the ACOR historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Acorda Therapeutics. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this ACOR Historical PE Ratio page.

What is the average historical PE for ACOR based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The ACOR historical PE ratio using the annualized quarterly earnings method works out to 52.0.

What is the average historical PE for ACOR based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The ACOR historical PE ratio using the TTM earnings method works out to 36.2.

On this page we presented the ACOR Historical PE Ratio information for Acorda Therapeutics' stock. The average ACOR historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 52.0. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average ACOR historical PE based on this TTM earnings result method is 36.2. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this ACOR historical PE result, against the recent PE: when this page was posted on 5/20/2022, the most recent closing price for ACOR had been 0.52, and the most recent quarterly earnings result, annualized, was 10.8. Meanwhile, the most recent TTM earnings summed to 8.76. From these numbers, we calculate the recent ACOR PE on 5/20/2022 based on annualized quarterly EPS was 0.0. Based on ACOR's history, that recent PE is low relative to the historical average, with the recent PE 100.0% lower than the historical average PE across our data set for Acorda Therapeutics. Looking at the recent ACOR PE on 5/20/2022 based on TTM EPS, we calculate the ratio at 0.1. Based on ACOR's history, that recent PE is low relative to the historical average, with the recent PE 99.7% lower than the average PE across our Acorda Therapeutics data set with TTM EPS used in the calculation at each period.

For self directed investors doing their due diligence on ACOR or any other given stock, valuation analysis for ACOR can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Acorda Therapeutics PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for ACOR. Thanks for visiting, and the next time you need to research ACOR Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: LNC market cap history, PGEN Videos, Funds Holding Viatris.

 

ACOR Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.